Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray

The mechanism of action for a new lead stilbene compound coded SK-03-92 with bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA) is unknown. To gain insight into the killing process, transcriptional profiling was performed on SK-03-92 treated vs. untreated S. aureus. Fou...

Full description

Bibliographic Details
Main Authors: William R. Schwan, Rebecca Polanowski, Paul M. Dunman, Sara Medina-Bielski, Michelle Lane, Marc Rott, Lauren Lipker, Amy Wescott, Aaron Monte, James M. Cook, Douglas D. Baumann, V.V.N. Phani Babu Tiruveedhula, Christopher M. Witzigmann, Cassandra Mikel, Md Toufiqur Rahman
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/6/3/17
_version_ 1818084277239152640
author William R. Schwan
Rebecca Polanowski
Paul M. Dunman
Sara Medina-Bielski
Michelle Lane
Marc Rott
Lauren Lipker
Amy Wescott
Aaron Monte
James M. Cook
Douglas D. Baumann
V.V.N. Phani Babu Tiruveedhula
Christopher M. Witzigmann
Cassandra Mikel
Md Toufiqur Rahman
author_facet William R. Schwan
Rebecca Polanowski
Paul M. Dunman
Sara Medina-Bielski
Michelle Lane
Marc Rott
Lauren Lipker
Amy Wescott
Aaron Monte
James M. Cook
Douglas D. Baumann
V.V.N. Phani Babu Tiruveedhula
Christopher M. Witzigmann
Cassandra Mikel
Md Toufiqur Rahman
author_sort William R. Schwan
collection DOAJ
description The mechanism of action for a new lead stilbene compound coded SK-03-92 with bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA) is unknown. To gain insight into the killing process, transcriptional profiling was performed on SK-03-92 treated vs. untreated S. aureus. Fourteen genes were upregulated and 38 genes downregulated by SK-03-92 treatment. Genes involved in sortase A production, protein metabolism, and transcriptional regulation were upregulated, whereas genes encoding transporters, purine synthesis proteins, and a putative two-component system (SACOL2360 (MW2284) and SACOL2361 (MW2285)) were downregulated by SK-03-92 treatment. Quantitative real-time polymerase chain reaction analyses validated upregulation of srtA and tdk as well as downregulation of the MW2284/MW2285 and purine biosynthesis genes in the drug-treated population. A quantitative real-time polymerase chain reaction analysis of MW2284 and MW2285 mutants compared to wild-type cells demonstrated that the srtA gene was upregulated by both putative two-component regulatory gene mutants compared to the wild-type strain. Using a transcription profiling technique, we have identified several cellular pathways regulated by SK-03-92 treatment, including a putative two-component system that may regulate srtA and other genes that could be tied to the SK-03-92 mechanism of action, biofilm formation, and drug persisters.
first_indexed 2024-12-10T19:51:20Z
format Article
id doaj.art-2b79c41766a14937a9b1eef60589aabb
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-12-10T19:51:20Z
publishDate 2017-09-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-2b79c41766a14937a9b1eef60589aabb2022-12-22T01:35:45ZengMDPI AGAntibiotics2079-63822017-09-01631710.3390/antibiotics6030017antibiotics6030017Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a MicroarrayWilliam R. Schwan0Rebecca Polanowski1Paul M. Dunman2Sara Medina-Bielski3Michelle Lane4Marc Rott5Lauren Lipker6Amy Wescott7Aaron Monte8James M. Cook9Douglas D. Baumann10V.V.N. Phani Babu Tiruveedhula11Christopher M. Witzigmann12Cassandra Mikel13Md Toufiqur Rahman14Department of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USASchool of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USADepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USAEmerging Technology Center for Pharmaceutical Development, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USADepartment of Mathematics and Statistics, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USADepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USADepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USADepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USAThe mechanism of action for a new lead stilbene compound coded SK-03-92 with bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA) is unknown. To gain insight into the killing process, transcriptional profiling was performed on SK-03-92 treated vs. untreated S. aureus. Fourteen genes were upregulated and 38 genes downregulated by SK-03-92 treatment. Genes involved in sortase A production, protein metabolism, and transcriptional regulation were upregulated, whereas genes encoding transporters, purine synthesis proteins, and a putative two-component system (SACOL2360 (MW2284) and SACOL2361 (MW2285)) were downregulated by SK-03-92 treatment. Quantitative real-time polymerase chain reaction analyses validated upregulation of srtA and tdk as well as downregulation of the MW2284/MW2285 and purine biosynthesis genes in the drug-treated population. A quantitative real-time polymerase chain reaction analysis of MW2284 and MW2285 mutants compared to wild-type cells demonstrated that the srtA gene was upregulated by both putative two-component regulatory gene mutants compared to the wild-type strain. Using a transcription profiling technique, we have identified several cellular pathways regulated by SK-03-92 treatment, including a putative two-component system that may regulate srtA and other genes that could be tied to the SK-03-92 mechanism of action, biofilm formation, and drug persisters.https://www.mdpi.com/2079-6382/6/3/17stilbenemicroarrayStaphylococcus aureusgene regulationdrug mechanism of actionsortasebiofilm
spellingShingle William R. Schwan
Rebecca Polanowski
Paul M. Dunman
Sara Medina-Bielski
Michelle Lane
Marc Rott
Lauren Lipker
Amy Wescott
Aaron Monte
James M. Cook
Douglas D. Baumann
V.V.N. Phani Babu Tiruveedhula
Christopher M. Witzigmann
Cassandra Mikel
Md Toufiqur Rahman
Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray
Antibiotics
stilbene
microarray
Staphylococcus aureus
gene regulation
drug mechanism of action
sortase
biofilm
title Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray
title_full Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray
title_fullStr Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray
title_full_unstemmed Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray
title_short Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray
title_sort identification of staphylococcus aureus cellular pathways affected by the stilbenoid lead drug sk 03 92 using a microarray
topic stilbene
microarray
Staphylococcus aureus
gene regulation
drug mechanism of action
sortase
biofilm
url https://www.mdpi.com/2079-6382/6/3/17
work_keys_str_mv AT williamrschwan identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT rebeccapolanowski identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT paulmdunman identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT saramedinabielski identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT michellelane identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT marcrott identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT laurenlipker identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT amywescott identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT aaronmonte identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT jamesmcook identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT douglasdbaumann identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT vvnphanibabutiruveedhula identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT christophermwitzigmann identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT cassandramikel identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray
AT mdtoufiqurrahman identificationofstaphylococcusaureuscellularpathwaysaffectedbythestilbenoidleaddrugsk0392usingamicroarray